Veterinary Medicines

SALMOPORC SCS lyophilisate and solvent for suspension for pigs

Not authorised
  • Salmonella enterica, subsp. enterica, serovar Choleraesuis, strain 431/261, Live
Download as PDF

Product identification

Medicine name:
SALMOPORC SCS lyophilisate and solvent for suspension for pigs
Salmoporc SCS liofilizat i rozpuszczalnik do sporządzania zawiesiny dla świń
Active substance:
  • Salmonella enterica, subsp. enterica, serovar Choleraesuis, strain 431/261, Live
Target species:
  • Pig
Route of administration:
  • Subcutaneous use
  • Oral use
  • Intramuscular use

Product details

Active substance and strength:
  • Salmonella enterica, subsp. enterica, serovar Choleraesuis, strain 431/261, Live
    8273.00
    colony forming unit(s)/dose
    /
    1.00
    colony forming unit(s)/dose
Pharmaceutical form:
  • Lyophilisate and solvent for emulsion for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Pig
      • Meat and offal
        3
        week
  • Oral use
    • Pig
      • Meat and offal
        3
        week
  • Intramuscular use
    • Pig
      • Meat and offal
        3
        week
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AE02
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Revoked
Authorised in:
  • Poland
Package description:
  • Lyophilised vaccine: 10 ml hydrolytic class 1 glass bottles, each containing 50 doses of vaccine and closed with bromobutyl rubber stopper and secured caps. Solvent: 50 ml hydrolytic class 2 glass bottles, each containing 50 ml of solvent, closed with bromobutyl rubber stopper and secured caps. Cardboard carton containing 50 doses (lyophilisate and solvent).
  • Lyophilised vaccine: 10 ml hydrolytic class 1 glass bottles, each containing 10 doses of vaccine and closed with bromobutyl rubber stopper and secured caps. Solvent: 10 ml hydrolytic class 2 glass bottles, each containing 10 ml of solvent, closed with bromobutyl rubber stopper and secured caps. Cardboard carton containing 10 doses (lyophilisate and solvent).

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Animal Health Polska Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • IDT Biologika GmbH
  • Solupharm Pharmazeutische Erzeugnisse GmbH
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 1325
Date of authorisation status change:
Reference member state:
  • Poland
Procedure number:
  • PL/V/0106/001/MR

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 31/03/2023
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 31/03/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 31/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."